Antibiotikaprofylakse ved vaginalplastik

Hvidovre Hospital0 个研究点目标入组 200 人开始时间: 2005年1月17日最近更新: 2012年4月3日

适应症

试验速览

暂无简介。

•Women age +18 with uterine prolapse grade I-II and/or cystocele and/or rectocele and/or enterocele grade I - IV and/or defects of the perineal body, in whom there is medical indication for vaginal repair, but no indication for vaginal hysterectomy or transvaginal suspension of the vaginal vault after prior hysterectomy.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Patients allergic to Cefuroxim.
•Patients in whom a vaginal hysterectomy or a transvaginal suspension of the vaginal vault or other major surgery is planned, where prophylactic antibiotic treatment is standard.
•Patients suffering from physical or mental disorders that will not allow them to give informed consent.
•Pregnant and nursing women.
•Drop outs are defined as:
•Patients where the surgeon find it indicated to perform a VH or VV-suspension, or laparotomy, where prophylactic antibiotic treatment is standard.
•Patients with adverse events. I.e. intraoperative bladder, ureter or bowl injury where antibiotics are obligatory.

发起方